...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >High-performance thin layer chromatography-based phytochemical and bioactivity characterisation of anticancer endophytic fungal extracts derived from marine plants
【24h】

High-performance thin layer chromatography-based phytochemical and bioactivity characterisation of anticancer endophytic fungal extracts derived from marine plants

机译:海洋植物抗癌内科真菌提取物的高性能薄层色谱 - 基于植物植物化学和生物活性表征

获取原文
获取原文并翻译 | 示例

摘要

Bioactive compounds from endophytic fungi exhibit diverse biological activities which include anticancer effect. Capitalising on the abundance of unexplored endophytes that reside within marine plants, this study assessed the anticancer potential of ethyl acetate endophytic fungal extracts (i.e. MBFT Tip 2.1, MBL 1.2, MBS 3.2, MKS 3 and MKS 3.1) derived from leaves, stem and fruits of marine plants that grow along Morib Beach, Malaysia. For identification of endophytic fungi, EF 4/ EF 3 and ITS 1/ ITS 4 PCR primer pairs were used to amplify the fungal 18S rDNA sequence and ITS region sequence, respectively. The resultant sequences were subjected to similarity search via the NCBI GenBank database. High-performance thin layer chromatography (HPTLC) hyphenated with bioassays was used to characterise the extracts in terms of their phytochemical profiles and bioactivity. Microchemical derivatisation was used to assess polyphenolic and phytosterol/ terpenoid content whereas biochemical derivatisation was used to establish antioxidant activities and alpha-amylase enzyme inhibition. The sulforhodamine B (SRB) assay was used to assess the anticancer effect of the extracts against HCT116 (a human colorectal cancer cell line). The present results indicated MBS 3.2 (Penicillium decumbens) as the most potent extract against HCT116 (IC50 = 0.16 mu g/mL), approximately 3-times more potent than 5-flurouracil (IC50 = 0.46 mu g/mL). Stepwise multiple regression method suggests that the anticancer effect of MBS 3.2 could be associated with high polyphenolic content and antioxidant potential. Nonlinear regression analysis confirmed that low to moderate alpha-amylase inhibition exhibits maximum anticancer activity. Current findings warrant further in-depth mechanistic studies. (C) 2020 Elsevier B.V. All rights reserved.
机译:内生真菌的生物活性化合物具有多种生物活性,包括抗癌作用。利用海洋植物中大量未经探索的内生真菌,本研究评估了从马来西亚莫里布海滩生长的海洋植物叶片、茎和果实中提取的乙酸乙酯内生真菌提取物(即MBFT Tip 2.1、MBL 1.2、MBS 3.2、MKS 3和MKS 3.1)的抗癌潜力。为了鉴定内生真菌,分别使用EF 4/EF 3和ITS 1/ITS 4 PCR引物对真菌18S rDNA序列和ITS区域序列进行扩增。结果序列通过NCBI GenBank数据库进行相似性搜索。高效薄层色谱法(HPTLC)与生物测定相结合,用于表征提取物的植物化学特征和生物活性。微化学衍生用于评估多酚和植物甾醇/萜类含量,而生化衍生用于确定抗氧化活性和α-淀粉酶抑制。磺基霍达明B(SRB)试验用于评估提取物对人结直肠癌细胞系HCT116的抗癌作用。目前的结果表明,MBS 3.2(平卧青霉)是抗HCT116最有效的提取物(IC50=0.16μg/mL),大约是5-氟脲嘧啶(IC50=0.46μg/mL)的3倍。逐步多元回归分析表明,MBS 3.2的抗癌作用可能与高多酚含量和抗氧化能力有关。非线性回归分析证实,低至中度α-淀粉酶抑制表现出最大的抗癌活性。目前的发现值得进一步深入的机理研究。(C) 2020爱思唯尔B.V.版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号